Multivariate model | ||||
Value | SE | t-value | p-value | |
OHA monotherapy | ||||
Change in HbA1c (%) | ||||
MPR (%) | −0.892 | 0.076 | −11.680 | 0.000 |
Constant | −0.002 | 0.073 | −0.030 | 0.974 |
MPR (%) | ||||
Age (years) | 0.002 | 0.000 | 10.110 | 0.000 |
Change in BMI (kg/m2) | −0.003 | 0.001 | −2.760 | 0.006 |
Baseline HbA1c (%) | −0.002 | 0.002 | −1.400 | 0.162 |
Change in total cholesterol | −0.016 | 0.002 | −7.270 | 0.000 |
Constant | 0.827 | 0.019 | 42.780 | 0.000 |
OHA dual therapy | ||||
Change in HbA1c (%) | ||||
MPR (%) | −0.859 | 0.155 | −5.550 | 0.000 |
Constant | −0.133 | 0.143 | −0.930 | 0.353 |
MPR (%) | ||||
Age (years) | 0.002 | 0.000 | 6.320 | 0.000 |
Change in BMI (kg/m2) | 0.004 | 0.001 | 2.420 | 0.015 |
Baseline HbA1c (%) | −0.007 | 0.002 | −3.400 | 0.001 |
Change in total cholesterol | −0.012 | 0.003 | −4.230 | 0.000 |
Constant | 0.874 | 0.023 | 37.300 | 0.000 |
OHA triple therapy | ||||
Change in HbA1c (%) | ||||
MPR (%) | −2.058 | 0.348 | −5.920 | 0.000 |
Constant | 0.840 | 0.319 | 2.630 | 0.009 |
MPR (%) | ||||
Age (years) | 0.001 | 0.001 | 2.170 | 0.031 |
Change in BMI (kg/m2) | −0.001 | 0.004 | −0.220 | 0.823 |
Baseline HbA1c (%) | −0.013 | 0.005 | −2.610 | 0.009 |
Change in total cholesterol | −0.016 | 0.008 | −1.930 | 0.054 |
Constant | 0.941 | 0.063 | 15.050 | 0.000 |
BMI, body mass index.